The Challenge of Hyponatremia

被引:97
作者
Adrogue, Horacio J. [2 ,3 ]
Madias, Nicolaos E. [1 ,4 ]
机构
[1] St Elizabeths Med Ctr, Dept Med, Div Nephrol, Boston, MA 02135 USA
[2] Baylor Coll Med, Methodist Hosp, Dept Med, Houston, TX 77030 USA
[3] Vet Affairs Med Ctr, Renal Sect, Houston, TX 77030 USA
[4] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2012年 / 23卷 / 07期
关键词
CENTRAL PONTINE MYELINOLYSIS; ANTIDIURETIC-HORMONE; SERUM SODIUM; EXTRAPONTINE MYELINOLYSIS; INAPPROPRIATE SECRETION; RAPID CORRECTION; TOLVAPTAN; OVERCORRECTION; MORTALITY; WATER;
D O I
10.1681/ASN.2012020128
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Treatment of hypotonic hyponatremia often challenges clinicians on many counts. Despite similar serum sodium concentrations, clinical manifestations can range from mild to life threatening. Some patients require active management, whereas others recover without intervention. Therapeutic measures frequently yield safe correction, yet the same measures can result in osmotic demyelination. To address this challenge, we present a practical approach to managing hyponatremia that centers on two elements: a diagnostic evaluation directed at the pathogenesis and putative causes of hyponatremia, the case-specific clinical and laboratory features, and the associated clinical risk; and a management plan tailored to the diagnostic findings that incorporates quantitative projections of fluid therapy and fluid losses on the patient's serum sodium, balances potential benefits and risks, and emphasizes vigilant monitoring. These principles should enable the clinician to formulate a management plan that addresses expeditiously three critical questions: Which of the determinants of the serum sodium are deranged and what is the underlying culprit? How urgent is the need for intervention? What specific therapy should be instituted and which are the associated pitfalls?
引用
收藏
页码:1140 / 1148
页数:9
相关论文
共 62 条
[1]   Consequences of inadequate management of hyponatremia [J].
Adrogué, HJ .
AMERICAN JOURNAL OF NEPHROLOGY, 2005, 25 (03) :240-249
[2]   Aiding fluid prescription for the dysnatremias [J].
Adrogue, HJ ;
Madias, NE .
INTENSIVE CARE MEDICINE, 1997, 23 (03) :309-316
[3]   Primary care:: Hyponatremia. [J].
Adrogué, HJ ;
Madias, NE .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (21) :1581-1589
[4]  
Adrogue HJ, 2004, J AM SOC NEPHROL, V15, P781
[5]  
Adrogue HJ, 1994, SALT WATER
[6]   Hyponatremia among runners in the Boston Marathon [J].
Almond, CSD ;
Shin, AY ;
Fortescue, EB ;
Mannix, RC ;
Wypij, D ;
Binstadt, BA ;
Duncan, CN ;
Olson, DP ;
Salerno, AE ;
Newburger, JW ;
Greenes, DS .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (15) :1550-1556
[7]   TREATING HYPONATREMIA - DAMNED IF WE DO AND DAMNED IF WE DONT [J].
BERL, T .
KIDNEY INTERNATIONAL, 1990, 37 (03) :1006-1018
[8]  
Berl T, 2008, J AM SOC NEPHROL, V19, P1076, DOI 10.1681/ASN.2007091042
[9]   The Adrogue-Madias formula revisited [J].
Berl, Tomas .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 2 (06) :1098-1099
[10]   A Patient With Severe Hyponatremia and Hypokalemia: Osmotic Demyelination Following Potassium Repletion [J].
Berl, Tomas ;
Rastegar, Asghar .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (04) :742-748